1. Home
  2. GPCR vs DGNX Comparison

GPCR vs DGNX Comparison

Compare GPCR & DGNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GPCR
  • DGNX
  • Stock Information
  • Founded
  • GPCR 2016
  • DGNX 2018
  • Country
  • GPCR United States
  • DGNX United Kingdom
  • Employees
  • GPCR N/A
  • DGNX N/A
  • Industry
  • GPCR
  • DGNX
  • Sector
  • GPCR
  • DGNX
  • Exchange
  • GPCR Nasdaq
  • DGNX NYSE
  • Market Cap
  • GPCR 1.1B
  • DGNX 1.1B
  • IPO Year
  • GPCR 2023
  • DGNX 2025
  • Fundamental
  • Price
  • GPCR $19.01
  • DGNX $66.50
  • Analyst Decision
  • GPCR Strong Buy
  • DGNX
  • Analyst Count
  • GPCR 7
  • DGNX 0
  • Target Price
  • GPCR $76.17
  • DGNX N/A
  • AVG Volume (30 Days)
  • GPCR 684.5K
  • DGNX 38.1K
  • Earning Date
  • GPCR 08-07-2025
  • DGNX 01-01-0001
  • Dividend Yield
  • GPCR N/A
  • DGNX N/A
  • EPS Growth
  • GPCR N/A
  • DGNX N/A
  • EPS
  • GPCR N/A
  • DGNX N/A
  • Revenue
  • GPCR N/A
  • DGNX $1,177,066.00
  • Revenue This Year
  • GPCR N/A
  • DGNX N/A
  • Revenue Next Year
  • GPCR N/A
  • DGNX N/A
  • P/E Ratio
  • GPCR N/A
  • DGNX N/A
  • Revenue Growth
  • GPCR N/A
  • DGNX N/A
  • 52 Week Low
  • GPCR $13.22
  • DGNX $3.60
  • 52 Week High
  • GPCR $47.48
  • DGNX $155.00
  • Technical
  • Relative Strength Index (RSI)
  • GPCR 33.96
  • DGNX N/A
  • Support Level
  • GPCR $18.50
  • DGNX N/A
  • Resistance Level
  • GPCR $19.40
  • DGNX N/A
  • Average True Range (ATR)
  • GPCR 1.18
  • DGNX 0.00
  • MACD
  • GPCR -0.17
  • DGNX 0.00
  • Stochastic Oscillator
  • GPCR 9.86
  • DGNX 0.00

About GPCR Structure Therapeutics Inc.

Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its differentiated technology platform leverages both structure-based drug discovery and expertise in computational chemistry to discover and develop small molecule therapeutics against G-protein coupled receptors (GPCRs). The group operates and manages its business as one reportable and operating segment, which is the business of research and development of medicines that target chronic diseases with unmet medical needs.

About DGNX DIGINEX LIMITED

Diginex Ltd is an investment holding company. It engaged in providing Environmental, Social, and Governance (ESG) reporting solution services, advisory services, and developing customization solutions. It is a sustainable RegTech business that empowers businesses and governments to streamline ESG, climate, and supply chain data collection and reporting. The company utilizes blockchain, AI, machine learning, and data analysis technology to change and increase corporate regulatory reporting and sustainable finance transparency. Its solutions and services enable companies to collect, evaluate, and share sustainability data through easy-to-use software.

Share on Social Networks: